Evidence map›Paper›PMID 31033240›Full record

ArticleFEBS open bio2019

A new split-luciferase complementation assay identifies pentachlorophenol as an inhibitor of apoptosome formation.

Amin Tashakor, Mahshid H-Dehkordi, Enda O'Connell, Sergi Gomez Ganau, Rafael Gozalbes, Leif A Eriksson, Saman Hosseinkhani, Howard O Fearnhead

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Identification of NLRP3International journal of molecular sciences · 2022
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Amin TashakorPharmacology and Therapeutics, School of Medicine, NUI Galway, Ireland.
Mahshid H-DehkordiPharmacology and Therapeutics, School of Medicine, NUI Galway, Ireland.
Enda O'ConnellGenomics and Screening Core, National Centre for Biomedical Engineering Science, NUI Galway, Ireland.
Sergi Gomez GanauPROTOQSAR, Valencia, Spain.
Rafael GozalbesPROTOQSAR, Valencia, Spain.
Leif A ErikssonUniversity of Gothenburg, Sweden.
Saman HosseinkhaniTarbiat Modares University, Tehran, Iran.
Howard O FearnheadPharmacology and Therapeutics, School of Medicine, NUI Galway, Ireland.
Instituto Valenciano de Competitividad Empresarial · ESOrbsen Therapeutics (Ireland) · IENational University of Ireland · IEOllscoil na Gaillimhe – University of Galway · IETarbiat Modares University · IRUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expense and time required for in vivo reproductive and developmental toxicity studies have driven the development of in vitro alternatives. Here, we used a new in vitro split luciferase-based assay to screen a library of 177 toxicants for inhibitors of apoptosome formation. The apoptosome contains seven Apoptotic Protease-Activating Factor-1 (Apaf-1) molecules and induces cell death by activating caspase-9. Apaf-1-dependent caspase activation also plays an important role in CNS development and spermatogenesis. In the in vitro assay, Apaf-1 fused to an N-terminal fragment of luciferase binds to Apaf-1 fused to a C-terminal fragment of luciferase and reconstitutes luciferase activity. Our assay indicated that pentachlorophenol (PCP) inhibits apoptosome formation, and further investigation revealed that PCP binds to cytochrome c. PCP is a wood preservative that reduces male fertility by ill-defined mechanisms. Although the data show that PCP inhibited apoptosome formation, the concentration required suggests that other mechanisms may be more important for PCP's effects on spermatogenesis. Nonetheless, the data demonstrate the utility of the new assay in identifying apoptosome inhibitors, and we suggest that the assay may be useful in screening for reproductive and developmental toxicants.

Indexed as

ApoptosisApoptosomesApoptotic Protease-Activating Factor 1Cell DeathCytochromes cHEK293 CellsHumansLuciferasesPentachlorophenolSignal TransductionSmall Molecule LibrariesToxicity TestsApoptosomesApoptotic Protease-Activating Factor 1Cytochromes cLuciferasesPentachlorophenolSmall Molecule LibrariesApaf-1apoptosomepentachlorophenolreproductive toxicityscreeningsplit luciferase complementation assay

Identifiers

PMID31033240
PMCPMC6609562
OpenAlexW2943190276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.